Abstract Details

Title BAF312, a Potent and Selective S1P1/5 Receptor Modulator Reverses Ongoing Chronic EAE in Mice

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 220

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Barbara Nuesslein-Hildesheim, PhD (Novartis Pharma AG)	Dr. Nuesslein-Hildesheim has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Nuesslein-Hildesheim has stock in Novartis Pharma AG.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Lee S. Chung, MD (University of Utah)	Dr. Chung has nothing to disclose.
	No disclosure on file
Paul A. Smith	No disclosure on file

��ɫ����